Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR

NCT05375474 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT05375474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05375474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Unknown status
Start date
July 27, 2023
Completion date
December 31, 2025
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antithrombotic therapy, bioprosthetic valve thrombosis, transcatheter aortic valve replacement